In this study, we have compared the levels of Tils, CCR5, Siglec-15, and PD-L1 in CNB and the corresponding SRS of 22 invasive breast carcinomas of no special type (IC-NST) and 22 invasive lobular carcinomas (ILC). This evidence concerns the gene CCR5 and invasive breast carcinoma.